ENTITY

Fujian Wanchen Biotechnology Group (300972 CH)

10
Analysis
Health Care • China
Fujian Wanchen Biotechnology Group Co.,Ltd. operates edible fungus cultivation businesses. The Company provides edible fungi factory cultivation, research and development, packaging, sales, deep processing, and other services. Fujian Wanchen Biotech nology also conducts leisure agriculture tourism businesses.
more
bullish•Busy Ming
•26 Jan 2026 08:55

Busy Ming Group (1768 HK) IPO - Thoughts on Valuation and the Outlook

​BUSY MING's attractive IPO pricing leaves upside potential, but concerns arise over franchisee profits and sustainability of growth model....

Logo
579 Views
Share
bullish•Busy Ming
•21 Jan 2026 09:01

Pre-IPO Busy Ming Group (PHIP Updates) - Some Points Worth the Attention

BUSY MING's IPO pricing is HK$229.6-236.6/share, with market value of HK$49.16-50.7bn. If based on our 2025, 2026, 2027 profit forecast, P/E would...

Logo
470 Views
Share
bullish•Busy Ming
•20 Jan 2026 16:47

Busy Ming (1768 HK) IPO: Valuation Insights

Busy Ming has launched an HKEx IPO to raise up to US$428 million. In this note, I present my forecasts and valuation. My analysis suggests that the...

Logo
514 Views
Share
bullish•Busy Ming
•20 Jan 2026 15:24

Aequitas: Busy Ming Pre-IPO- Priced at a Discount to Peers

​Busy Ming plans to raise $430m in its Hong Kong IPO. It is a rapidly growing food and beverage retailer in China with stores in prime locations....

Logo
372 Views
Share
bullish•Busy Ming
•27 Nov 2025 02:22

Busy Ming IPO Update: Cash-Generating Machine With Improving Gross Margins, IPO Is on the Horizon

Busy Ming Group is expected to IPO in Hong Kong soon. In my insight, I discuss in-depth analysis of business and operating metrics, IPO valuation...

Share
x